Hassan Yaish, MD, Hematology, Salt Lake City, UT, Primary Children's Hospital

HassanMYaishMD

Hematology Salt Lake City, UT

Hematologic Oncology

Professor, Pediatrics, University of Utah School of Medicine

Dr. Yaish is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yaish's full profile

Already have an account?

Education & Training

  • William Beaumont Hospital
    William Beaumont HospitalRESIDENCY
  • William Beaumont Hospital
    William Beaumont HospitalRESIDENCY
  • William Beaumont Hospital
    William Beaumont HospitalINTERNSHIP
  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2007 - 2011
  • UT State Medical License
    UT State Medical License 2003 - 2022
  • FL State Medical License
    FL State Medical License 2003 - 2021
  • MI State Medical License
    MI State Medical License 1973 - 2024
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study
    Hassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
    Hassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
    Hassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Final Results from a Non-Interventional Safety and Efficacy Study of a VWF/FVIII Concentrate (wilate®) in Patients with Von Willebrand Disease 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • Arabic

Hospital Affiliations